Acquired badge _edited.png
Cellsonics
Enzyme-free, easily obtainable single cells & nucleic acids from solid tissue
INVESTMENt

June, 2019

Sector

Science

FUND

Fund I

location

Northern California

co-investors

Vertical Venture Partners

Image-empty-state_edited.jpg

Steve Levers

CEO

Quintuple aim
Alertive.png

Cellsonics is revolutionizing single-cell sample preparation, delivering the individual characteristics of each sample for a precision medicine approach to the analysis, treatment, and diagnosis of disease. Their simplified solution uses SimpleFlow™ technology to set new standards for obtaining single cells from solid tissue with unparalleled speed, quality, and sample integrity. In addition, the integration of novel BLU™ energy into a fluidic circuit in a single-use cartridge provides a complete automated dissociation workflow solution not possible using conventional methods.